IR Overview

Mylan Inc.

Mylan Inc., with a presence in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest – and highest quality – product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.

Latest News

08/11/08	Mylan Named Manufacturer of the Year by AmerisourceBergen Corporation
08/06/08	Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
08/06/08	Mylan Creates New Women's Health Care Franchise; Signs Agreement with Famy Care to Develop and Supply 22 Oral Contraceptive Products
07/28/08	Mylan Acquires Remaining Interest in Somerset Joint Venture From Watson

Copyright © 2007 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data is provided by Interactive Real Time Services Data and subject to the Term of Use .
Changes in price and volume are subject to market activity.

Stock Quote

MYL (common stock)

08/27/08 4:00 p.m. ET
Minimum 20 minute delay

Exchange	NYSE (US Dollar)
Last Trade	$13.19
Change (%)	0.12 (0.90%)
Volume	3,376,600

Receive E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!